Cingulate (CINGW) Expected to Post Quarterly Earnings on Tuesday

Cingulate (NASDAQ:CINGW) is projected to issue its results before the market opens on Tuesday, August 18th. Analysts expect the company to announce earnings of ($0.6250) per share and revenue of $0.1670 million for the quarter.

Cingulate Price Performance

NASDAQ CINGW opened at $0.01 on Tuesday. The company’s fifty day simple moving average is $0.02 and its 200-day simple moving average is $0.03. Cingulate has a 52 week low of $0.01 and a 52 week high of $0.12.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.